LILLY ELI & PHARMACEUTICAL DIV -- CEFTAZIDIME FOR INJECTION
=======================================================
Material Safety Data Sheet
=======================================================
NIIN: 01-231-4808
MSDS Num: BWXVP
MSDS NAME: CEFTAZIDIME FOR INJECTION
Responsible Party
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Info Phone: 317-276-2000
Emergency Phone Number: 317-276-2000
Review Ind: Y
Published: Y
=======================================================
Preparer Co. when other than Responsible Party Co.
=======================================================
Assigned Ind: Y
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
=======================================================
Contractor Summary
=======================================================
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
Name: LILLY ELI AND CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
=======================================================
Item Description Information
=======================================================
Item Name: CEFTAZIDIME FOR INJECTION,USP
Unit of Issue: PG
UI Container Qty: 1
=======================================================
Ingredients
=======================================================
Cas: 78439-06-2
RTECS #: UU2230000
Name: CEFTAZIDIME PENTAHYDRATE *95-1*
% Wt: 88-90
-----------------------------
Cas: 497-19-8
RTECS #: VZ4050000
Name: SODIUM CARBONATE (SODA ASH, TRONA, CARBONIC ACID, CRYSTOL CARBONATE,
DISODIUM CARBONATE)
% Wt: 10-12
=======================================================
Health Hazards Data
=======================================================
Route Of Entry Inds - Inhalation: YES
Skin: NO
Ingestion: NO
Carcinogenicity Inds - NTP: NO
IARC: NO
OSHA: NO
Effects of Exposure: EYES: IRRITATION. ALLERGIC REACTIONS HAVE BEEN REPORTED
INCLUDING ANAPHYLAXIS.
Explanation Of Carcinogenicity: NONE
Signs And Symptions Of Overexposure: IRRITATION, RASH, NASAL CONGESTION, COUGH,
DRY THROAT, GI UPSET.
Medical Cond Aggravated By Exposure: PENICILLIN/CEPHALOSPORIN HYPERSENSITIVITY.
First Aid: EYES: FLUSH W/PLENTY OF WATER. SKIN: WASH W/PLENTY OF SOAP &
WATER. INHALATION: REMOVE TO FRESH AIR. GIVE CPR IF NEEDED. INGESTION: DON'T
INDUCE VOMITING. IF AVAILABLE, GIVE 6-8 HEAPING TEASPOONS OF A CTIVATED
CHARCOAL W/2-3 GLASSES OF WATER. DON'T GIVE ANYTHING BY MOUTH TO AN
UNCONSCIOUS PERSON. OBTAIN MEDICAL ATTENTION IN ALL CASES.
=======================================================
Handling and Disposal
=======================================================
Spill Release Procedures: CONTAIN DRY MATERIAL BY SWEEPING UP/VACUUMING.
VACUUMING MAY DISPERSE DUST IF APPROPRIATE DUST COLLECTION FILTER ISN'T USED.
BE AWARE OF POTENTIAL DUST EXPLOSION WHEN USING ELECTRICAL EQUIPMENT. WEAR
PROTECTIVE EQUIPMENT INCLUDING EYE PROTECTION.
Waste Disposal Methods: DISPOSE OF CLEANUP MATERIALS & WASTE RESIDUE
IAW/FEDERAL, STATE & LOCAL REGULATIONS.
=======================================================
Fire and Explosion Hazard Information
=======================================================
Extinguishing Media: WATER, CO2, DRY CHEMICAL, FOAM, HALON.
Unusual Fire/Explosion Hazard: AS A FINELY DIVIDED MATERIAL, MAY FORM DUST
MIXTURES IN AIR WHICH COULD EXPLODE IF SUBJECTED TO AN IGNITION SOURCE.
=======================================================
Control Measures
=======================================================
Respiratory Protection: WEAR AN APPROVED RESPIRATOR. AIRLINE-SUPPLIED,
HOOD-TYPE RESPIRATORS ARE PREFERRED IN PRODUCTION SETTINGS.
Ventilation: LABORATORY FUME HOOD/LOCAL EXHAUST.
Protective Gloves: CHEMICAL RESISTANT
Eye Protection: CHEMICAL GOOGLES &/FACE SHIELD
Other Protective Equipment: SAFETY GLASSES, BODY COVERING, SHOWER
Work Hygienic Practices: REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
=======================================================
Physical/Chemical Properties
=======================================================
PH: 5-7.5
Solubility in Water: COMPLETE
Appearance and Odor: WHITE TO CREAM COLORED CRYSTALLINE POWDER W/NO ODOR.
=======================================================
Reactivity Data
=======================================================
Stability Indicator: YES
Stability Condition To Avoid: IGNITION SOURCES.
Materials To Avoid: STRONG OXIDIZING AGENTS, PEROXIDES, PERMANGANATES, NITRIC
ACID.
Hazardous Decomposition Products: TOXIC FUMES.
Hazardous Polymerization Indicator: NO
=======================================================
Toxicological Information
=======================================================
=======================================================
Ecological Information
=======================================================
=======================================================
MSDS Transport Information
=======================================================
=======================================================
Regulatory Information
=======================================================
=======================================================
Other Information
=======================================================
=======================================================
HAZCOM Label
=======================================================
MSDS NAME: CEFTAZIDIME FOR INJECTION
Assigned IND: Y
Company: LILLY ELI & CO PHARMACEUTICAL DIV
Street: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN
Zipcode: 46285
Health Emergency Phone: 317-276-2000
Label Required IND: Y
Date Of Label Review: 12/16/1998
Status Code: C
Label Date: 12/16/1998
Origination Code: G
Hazard And Precautions: EYES: IRRITATION. ALLERGIC REACTIONS HAVE BEEN REPORTED
INCLUDING ANAPHYLAXIS.
IRRITATION, RASH, NASAL CONGESTION, COUGH, DRY
THROAT, GI UPSET.
=======================================================
Disclaimer (provided with this information by the compiling agencies): This
information is formulated for use by elements of the Department of Defense.
The United States of America in no manner whatsoever expressly or implied
warrants, states, or intends said information to have any application, use or
viability by or to any person or persons outside the Department of Defense
nor any person or persons contracting with any instrumentality of the United
States of America and disclaims all liability for such use. Any person
utilizing this instruction who is not a military or civilian employee of the
United States of America should seek competent professional advice to verify
and assume responsibility for the suitability of this information to their
particular situation regardless of similarity to a corresponding Department
of Defense or other government situation.
*** END OF RECORD *** |
|
|